Patent · US Active

Anti-Sialyl Tn chimeric antigen receptors

US11279769B2 · kind B2 · utility

0Cited by
3References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2016
Grant dateMar 22, 2022
Priority date—
Expiry dateJun 10, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides improved compositions for adoptive cell therapies for cancers that express the glycoepitope STn on TAG-72.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.